Neurons were treated with 100 µ DA for 24 h in the presence or absence of the D2 receptor antagonists spiperone (SPI) and haloperidol (HAL), and the D1 receptor antagonist SCH23390 (SCH). () Quantification of the catalytic activity of mCII (succinate dehydrogenase). () Western blot analysis of Fp and Ip corresponding to the culture wells analyzed for mCII activity above. In both cases, the blockade of D2 receptors abolishes the loss of mCII triggered by DA, while D1 receptor blockade has no effect. * < 0.05; ANOVA and Fisher's PLSD test.<p><b>Copyright information:</b></p><p>Taken from "Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex I...
Drugs acting at dopamine D2 receptors (D2R) are commonly used to alleviate symptoms produced by dise...
<p>(A) The mRNA expressions of dopamine receptor subtypes including D<sub>1</sub>R, D<sub>2</sub>R, ...
The intraperitoneal administration of SCH 23390, a selective D1 receptor antagonist, produced catale...
Measurement of Ip and Fp protein expression levels as indicated by western blotting, and mCII activi...
Y-79 human retinoblastoma cells can be induced to express significant quantities of functional D2 do...
Two isoforms of the dopamine (DA) D2 receptor are generated from the same gene by alternative splici...
Cell viability assessed by the MTT assay after treatment for 24 h with 3-NP (75 µ), an irreversible ...
D2-like dopamine receptors mediate functional changes via activation of inhibitory G proteins, inclu...
Two isoforms of the dopamine (DA) D2 receptor are generated from the same gene by alternative splici...
A rat D2L dopamine receptor, a splice variant of the D2 receptor, has recently been cloned. When tra...
The D2-Dopamine Receptor (D2R) is a membrane-inserted receptor protein that is important clinically ...
<p><b>A.</b> Flow cytometric analysis of dopamine-induced internalization of D2 dopamine receptors. ...
Dopamine (DA) is an important neuromodulator of the central nervous system; an accurate control of D...
The dopamine D2 receptor (D2R) is known to elicit effects through activating two major signaling pat...
The cloning of the dopamine (DA) D2 receptor now permits the characterization and regulation of D2 m...
Drugs acting at dopamine D2 receptors (D2R) are commonly used to alleviate symptoms produced by dise...
<p>(A) The mRNA expressions of dopamine receptor subtypes including D<sub>1</sub>R, D<sub>2</sub>R, ...
The intraperitoneal administration of SCH 23390, a selective D1 receptor antagonist, produced catale...
Measurement of Ip and Fp protein expression levels as indicated by western blotting, and mCII activi...
Y-79 human retinoblastoma cells can be induced to express significant quantities of functional D2 do...
Two isoforms of the dopamine (DA) D2 receptor are generated from the same gene by alternative splici...
Cell viability assessed by the MTT assay after treatment for 24 h with 3-NP (75 µ), an irreversible ...
D2-like dopamine receptors mediate functional changes via activation of inhibitory G proteins, inclu...
Two isoforms of the dopamine (DA) D2 receptor are generated from the same gene by alternative splici...
A rat D2L dopamine receptor, a splice variant of the D2 receptor, has recently been cloned. When tra...
The D2-Dopamine Receptor (D2R) is a membrane-inserted receptor protein that is important clinically ...
<p><b>A.</b> Flow cytometric analysis of dopamine-induced internalization of D2 dopamine receptors. ...
Dopamine (DA) is an important neuromodulator of the central nervous system; an accurate control of D...
The dopamine D2 receptor (D2R) is known to elicit effects through activating two major signaling pat...
The cloning of the dopamine (DA) D2 receptor now permits the characterization and regulation of D2 m...
Drugs acting at dopamine D2 receptors (D2R) are commonly used to alleviate symptoms produced by dise...
<p>(A) The mRNA expressions of dopamine receptor subtypes including D<sub>1</sub>R, D<sub>2</sub>R, ...
The intraperitoneal administration of SCH 23390, a selective D1 receptor antagonist, produced catale...